Centrifugation versus filtration-based cell salvage: impact on perioperative bleeding in cardiac surgery—the COLTRANE randomised clinical trial – study protocol
Authors:
Open Access
- 16 July 2025
- Vol. 15 (7) , e099423
Abstract
Introduction Cardiac surgery remains a high-risk procedure for bleeding despite advances in patient blood management. Conventional centrifugation-based autotransfusion devices primarily recover red blood cells, losing platelets and coagulation factors. The SAME autotransfusion device (i-SEP, Nantes, France) introduces an innovative filtration-based approach, recovering erythrocytes, leucocytes and platelets to enhance perioperative haemostasis. The main objective is to determine whether the filtration-based SAME device reduces significant perioperative bleeding compared with the centrifugation-based system in high-risk cardiac surgery patients. Methods and analysis The Centrifugation-based vs filtration-based intraOperative cell saLvage on qualiTy of peRioperAtive haemostasis iN cardiac surgEry (COLTRANE) trial is a multicentre, parallel-group, single-blinded, superiority-randomised clinical trial. Conducted over 19 months in 10 French hospitals, the study will target patients at high risk of bleeding undergoing on-pump cardiac surgery via sternotomy. A total of 570 patients (285 per group) are required to achieve 80% statistical power for detecting clinically significant differences. Eligible patients will be randomised to either a centrifugation-based or filtration-based autotransfusion group. Both groups will follow standardised perioperative and cardiopulmonary bypass management, with the devices used only intraoperatively. The primary outcome is the proportion of patients with clinically significant perioperative bleeding defined as classes 2 to 4 of the Universal Definition of Perioperative Bleeding. The secondary outcomes include device efficiency and safety, perioperative haemostasis, lengths of intensive care unit and hospital stays, early postoperative morbidity and 30-day all-cause mortality. Ancillary studies will be performed to evaluate cell recovery and washing performance, the viscoelastic properties of retransfused blood (Quantra Qplus; Stago, Asnières-sur-Seine, France), and the effect of salvaged leucocytes on postoperative inflammation and immune function. Ethics and dissemination This trial has received a favourable opinion from the Committee for the Protection of Persons and authorisation from the French authorities (Comité de protection des personnes Nord Ouest, IDRCB: 2023-A02566-39). Protocol V.1.1 was approved on 22 January 2024. The trial is registered on ClinicalTrials.gov (NCT06425614). The findings will be disseminated through oral communications at national and international scientific meetings and peer-reviewed journal publications. Individual participant data will be made available on reasonable request to qualified researchers, following review and approval by the study sponsor and ethics committee. Trial registration number ClinicalTrials.gov, NCT06425614.Keywords
Funding Information
- French Ministry of Health (PHRC-N 2021-0296)
This publication has 30 references indexed in Scilit:
- POBS-Card, a new score of severe bleeding after cardiac surgery: Construction and external validationJTCVS Open, 2024
- Consensus Statement: Hemostasis Trial Outcomes in Cardiac Surgery and Mechanical SupportThe Annals of Thoracic Surgery, 2022
- The ACTA PORT-score for predicting perioperative risk of blood transfusion for adult cardiac surgeryBritish Journal of Anaesthesia, 2017
- Reexploration for Bleeding and Its Association With Mortality After Cardiac SurgeryThe Annals of Thoracic Surgery, 2016
- Safety of Salvaged Blood and Risk of Coagulopathy in Cardiac SurgerySeminars in Thrombosis and Hemostasis, 2016
- Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypassThrombosis Research, 2014
- Universal definition of perioperative bleeding in adult cardiac surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Blood Transfusion and Infection After Cardiac SurgeryThe Annals of Thoracic Surgery, 2013
- Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delayThe Annals of Thoracic Surgery, 2004
- Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasisThe Annals of Thoracic Surgery, 1995